ST6GAL1 and glioblastoma: GD3 has been identified as a marker for glioblastoma stem cells (GSCs) and overexpression of ST6Gal1 and GD3 synthase (GD3S) has been shown to enhance CSC properties by stabilizing oncogenic signaling pathways like c-MET signaling (252).